Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Endocrine Oncology (Bristol, England)|November 28, 2025
Variable GLP-1 receptor expression across diverse neuroendocrine neoplasms: implications for incretin therapiesPo Hien Ear, Sophia A Hueser, Reese E Townsend, et al.
EJNMMI Reports|November 29, 2024
Inter- and intra-tumoral heterogeneity on [<sup>68</sup>Ga]Ga-DOTA-TATE/[<sup>68</sup>Ga]Ga-DOTA-TOC PET/CT predicts response to [<sup>177</sup>Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patientsCamila Gadens Zamboni, Ayca Dundar, Sanchay Jain, et al.
Annals of Surgical Oncology|November 6, 2024
Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine TumorsLuis C Borbon, Scott K Sherman, Patrick J Breheny, et al.
Journal of Gastrointestinal Cancer|March 9, 2020
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid SyndromeJoseph S Dillon, Matthew H Kulke, Dieter Hörsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2018
<sup>90</sup>Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide TherapyYusuf Menda, Mark T Madsen, Thomas M O'Dorisio, et al.
The Oncologist|January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid SyndromeLowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
Annals of Surgical Oncology|September 13, 2021
Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal ResectionCatherine G Tran, Scott K Sherman, Mohammed O Suraju, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2017
Localization of Unknown Primary Site with <sup>68</sup>Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine TumorYusuf Menda, Thomas M O'Dorisio, James R Howe, et al.
American Journal of Medical Genetics. Part A|March 2, 2021
Presacral neuroendocrine tumors associated with the Currarino syndromeAaron T Scott, Jonathon B Tessmann, Terry Braun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 7, 2018
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or ParagangliomaDaniel A Pryma, Bennett B Chin, Richard B Noto, et al.
Pageof 6